Antianaerobic Activity of Sulopenem Compared to Six Other Agents-Reference-Cited by-同舟云学术

Antianaerobic Activity of Sulopenem Compared to Six Other Agents

Published:2009-05 Issue:5 Volume:53 Page:2163-2170
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Ednie Lois M.¹,Appelbaum Peter C.¹

Affiliation:

1. Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033

Abstract

ABSTRACT Agar dilution MIC methodology was used to compare the activity of sulopenem with those of amoxicillin/clavulanate, ampicillin/sulbactam, piperacillin-tazobactam, imipenem, clindamycin, and metronidazole against 431 anaerobes. Overall, MIC 50 / 90 values were as follows: sulopenem, 0.25/1.0 μg/ml; amoxicillin/clavulanate, 0.5/2.0 μg/ml; ampicillin/sulbactam, 0.5/4.0 μg/ml; piperacillin/tazobactam, 0.25/8.0 μg/ml; imipenem, 0.06/1.0 μg/ml; clindamycin, 0.25/16.0 μg/ml; and metronidazole, 1.0/4.0 μg/ml.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01557-08

Reference17 articles.

1. Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance

2. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1990. Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium. Eur. J. Clin. Microbiol. Infect. Dis.9:47-50.

3. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers

4. Appelbaum, P. C., S. K. Spangler, and M. R. Jacobs. 1993. Susceptibility of 539 gram-positive and -negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam. J. Antimicrob. Chemother.32:223-231.

5. Appelbaum, P. C., S. K. Spangler, G. A. Pankuch, A. Philippon, M. R. Jacobs, R. Shiman, E. J. C. Goldstein, and D. Citron. 1994. Characterization of a β-lactamase from Clostridium clostridioforme. J. Antimicrob. Chemother.33:33-40.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies;Expert Opinion on Investigational Drugs;2024-05-09

2. In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program;Journal of Antimicrobial Chemotherapy;2023-04-12

3. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria;Drugs;2022-03-16

4. β-lactam antibiotics: An overview from a medicinal chemistry perspective;European Journal of Medicinal Chemistry;2020-12

5. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?;International Journal of Antimicrobial Agents;2019-03